Jan 30, 2016

The impact of sequencing on diagnosis and treatment of malignant melanoma

Expert Review of Molecular Diagnostics
Roberta CastiglioneReinhard Büttner


Melanoma is one of the clinically most important cancer types considering its high mortality rate and that it is commonly diagnosed in relatively young people. With the advent of targeted therapies and, more recently, immune checkpoint inhibitors, more treatment options are available resulting in higher patient survival rates. However, the successful application of these targeted therapies critically depends on the reliable detection of molecular aberrations. Today, massively parallel sequencing techniques enable us to analyze large sets of genes in a relatively short time. It has allowed increased knowledge of acquired somatic mutations in melanoma and has helped to identify new targets for personalized therapy, and potentially may help to predict response to immune therapies. Described here are the development of sequencing techniques, how their improvement has changed diagnosis, prognosis and management of malignant melanoma and the future perspectives of melanoma diagnostics in the routine clinical setting.

  • References91
  • Citations


  • References91
  • Citations


  • This paper may not have been cited yet.

Mentioned in this Paper

BRAF protein, human
Somatic Mutation
Parallel Study
Nucleic Acid Sequencing
Tumor Markers
Melanoma vaccine

Related Feeds

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Related Papers

Pharmacogenomics and Personalized Medicine
Rima ChakrabortyNneka I Comfere
Zhonghua bing li xue za zhi Chinese journal of pathology
Liang ChengXi Wang
Biochimica Et Biophysica Acta
Deepak NagrathNadege Bellance
© 2020 Meta ULC. All rights reserved